Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Anal Swab in COVID-19 Patients.
Koesnoe S, Hidayat R, Aini MH, Fani DN, Widjaya N. Koesnoe S, et al. Among authors: aini mh. Acta Med Indones. 2022 Jul;54(3):451-455. Acta Med Indones. 2022. PMID: 36156487 Free article.
Evaluation of SARS-CoV-2 Antibody Response Post Third Dose COVID-19 mRNA Vaccination at Universitas Indonesia Hospital.
Hidayat R, Mustika AP, Avisha F, Djuliannisaa Z, Winari DD, Putri RA, Lisman HM, Davin V, Fathi GC, Widhani A, Aini MH, Yudhistira Y, Azizah S, Rahmadani M, Istanti ND, Giantini A. Hidayat R, et al. Among authors: aini mh. Acta Med Acad. 2022 Aug;51(2):69-78. doi: 10.5644/ama2006-124.374. Acta Med Acad. 2022. PMID: 36317998 Free PMC article.
Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel.
Hidayat R, Mustika AP, Avisha F, Djuliannisaa Z, Winari DD, Putri RA, Lisman HM, Davin V, Widhani A, Aini MH, Rahmadani M, Istanti ND, Giantini A. Hidayat R, et al. Among authors: aini mh. Vaccines (Basel). 2022 May 30;10(6):877. doi: 10.3390/vaccines10060877. Vaccines (Basel). 2022. PMID: 35746485 Free PMC article.
Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia.
Shakinah S, Aini MH, Sekartini R, Soedjatmiko, Medise BE, Gunardi H, Yuniar I, Indawati W, Koesnoe S, Harimurti K, Maria S, Wirahmadi A, Sari RM, Setyaningsih L, Surachman F. Shakinah S, et al. Among authors: aini mh. Vaccines (Basel). 2024 Apr 1;12(4):371. doi: 10.3390/vaccines12040371. Vaccines (Basel). 2024. PMID: 38675753 Free PMC article.